aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Carmot Therapeutics, based in San Francisco, is a biotechnology company dedicated to discovering and developing medicines for inflammatory, metabolic, and neurodegenerative diseases. Their core mission is to improve clinical outcomes for people living with obesity and diabetes through innovative therapies. Utilizing their proprietary Chemotype Evolution technology, Carmot aims to expand the therapeutic potential and address unmet medical needs in these areas.
Carmot Therapeutics has made significant strides in the biotechnology sector by focusing on groundbreaking scientific research and development. Their commitment to improving the lives of individuals with metabolic diseases has positioned them as a key player in the industry. The company's innovative approach and dedication to science have garnered attention and support from various stakeholders, contributing to their growing impact in the field of medicine.
Operating Status
Active
Ownership Type(s)
Venture Capital, Private
Main Product(s)
Drug Development
Technology
Biotech
Tags
Healthtech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
United States
When was Carmot Therapeutics founded?
Carmot Therapeutics was founded in 2008.
Where is Carmot Therapeutics's headquarters located?
Carmot Therapeutics's headquarters is located in Berkeley, CA, US.
When was Carmot Therapeutics's last funding round?
Carmot Therapeutics's most recent funding round was for $150M (USD) in May 2023.
How many employees does Carmot Therapeutics have?
Carmot Therapeutics has 72 employees as of Feb 5, 2024.
How much has Carmot Therapeutics raised to-date?
As of July 05, 2023, Carmot Therapeutics has raised a total of $384.8M (USD) since May 25, 2023.
Add Comparison
Total Raised to Date
$384.8M
USD
Last Update May 25, 2023
Last Deal Details
$150M
USD
May 25, 2023
Series E
Total Employees Over Time
72
As of Feb 2024
Carmot Therapeutics Address
740 Heinz Ave
Berkeley,
California
94710
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts